Omega Therapeutics’ $144.6 Million IPO

Martina Bellini
Tagged:

Goodwin Procter advised Goldman Sachs & Co. LLC and the other underwriters on the deal.Omega Therapeutics, Inc. (Nasdaq: OMGA), a development-stage biotechnology company leveraging its OMEGA Epigenomic…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

…

This content is for Standard 1 Year members only.
Login Join Now